Choose a cosmetic manufacturer by starting with your product, target market, and essential requirements. Give potential suppliers the same brief, identify the actual facilities and parties involved, and compare their proposals against evidence for the work they will perform. Resolve mandatory legal and technical questions before using price or a weighted score to choose between offers.
A good sample, an attractive factory photograph, or a certificate can be useful information. None alone establishes that a supplier can make your particular formula in your chosen package, support your claims, meet the requirements of your destination, and maintain the agreed quality over time. The decision needs a set of connected answers about scope, records, responsibilities, rights, cost, and continuity.
This guide is for beauty brand owners, product managers, and sourcing teams comparing potential partners. It provides an international buying framework and identifies selected US and EU questions. The appropriate checks depend on the actual product, facilities, legal entities, and markets.
Start with your product and non-negotiable requirements
Before requesting quotations, describe what you need a manufacturer to do. Identify the product format, intended use, target customer, proposed claims, destination markets, formula starting point, packaging direction, estimated quantity, and any required documents. Note which information is confirmed and which is still an assumption.
Separate non-negotiable conditions from preferences. A mandatory condition might arise from applicable law, a required product specification, or a business decision that the project cannot proceed without. A preference might concern a particular presentation, communication format, or service arrangement that can be discussed. The exact gates depend on the project; do not copy a checklist from a different product without review.
Include an unknown status. A supplier should not be treated as having met a condition simply because the question has not yet been answered. Assign someone to obtain and assess the evidence. If the missing item concerns a necessary requirement, place the decision on hold until the responsible reviewer can resolve it.
For example, a brand planning a leave-on product for the EU needs to identify how the relevant responsible-person and safety-assessment work will be handled. The EU framework has specific requirements for cosmetic products, including a responsible person and a product safety report. [6] A brand considering the United States needs to identify the applicable entities, product classification, and responsibilities under the relevant US rules. [2] A supplier's general statement that it “exports worldwide” does not answer either question.
Decide who on your team will review technical, quality, regulatory, commercial, and legal information. One person may coordinate the process, but different decisions can require different expertise. A clear decision owner helps prevent a commercial deadline from becoming an accidental approval of an unresolved risk.
Build a comparable brief and request for quotation
A request for quotation, or RFQ, is most useful when each supplier responds to the same defined scope. If one offer covers an existing formula and basic packaging while another includes development, testing, and decorated components, their unit prices do not describe the same work. A comparison requires the differences to be visible.
Give each potential supplier the same version of the brief. Include the intended product and market, formula or sample starting point, packaging and artwork assumptions, expected quantities, desired deliverables, and the stage at which you need a decision. Identify any information that is confidential and share it through an agreed channel only when appropriate.
Ask the supplier to organize its response around the following items:
- The work it proposes to perform and the work it excludes.
- The legal entity and facility responsible for each major activity.
- Any proposed subcontractors or third-party laboratories, where known.
- The sample, formula, packaging, and artwork assumptions used in the quote.
- The evaluations, reports, and market-support activities included or quoted separately.
- The quantities, currency, payment terms, delivery basis, and period for which the quote applies.
- The decisions or information needed before the proposal can be confirmed.
Request a schedule that shows dependencies rather than a single unexplained launch date. Development feedback, packaging availability, technical review, artwork approval, and production planning may affect the sequence. Ask which activities can proceed in parallel and which depend on an earlier decision. Treat a preliminary schedule as conditional until the underlying scope is agreed.
If suppliers propose alternatives, record them separately. One may suggest a standard component instead of a custom package; another may propose a different sample route. Those alternatives can be valuable, but the buyer needs to see how they differ from the common brief. Ask for the effect on appearance, rights, evaluation, minimums, and cost where applicable.
Keep a question log with the supplier's answer, the evidence provided, the date, and the reviewer. An unanswered item remains open. Do not convert a sales conversation into a confirmed commitment until the relevant details appear in the agreed documents.
Verify the supplier's identity and the work location
Start with the entity that will sign the contract. Ask for its legal name and the location of each activity relevant to your order. A business may develop a formula at one site, manufacture bulk product at another, fill it at a third, or use an external laboratory. The arrangement can be appropriate, but the buyer needs to know which parties and locations are involved.
Compare the names and addresses across the proposal, contract, invoices, certificates, audit reports, and other documents. If the entity on a certificate is different from the proposed manufacturer, ask about the relationship and whether the certificate covers the actual work. Confirm information through an independent official or issuing-body source where one is lawfully accessible. Record the source and date of the check.
Ask the supplier to describe experience with the relevant format and process. A catalog can show examples of what a company presents to buyers, but it does not establish that the exact product was made at the proposed site or that the facility can perform every requested service. Ask which stages the supplier performs itself, which are arranged through others, and what evidence can be shared for the proposed operation.
Do not assume that a photograph, video, or address proves the current capacity or status of a site. If a visit or remote review is possible, agree what it will cover and who will attend. A visit can help the buyer understand the operation, but it is only one input; a short tour does not replace a review of the relevant documents, product, and responsibilities.
An unclear answer is a reason to investigate, not automatic proof of wrongdoing. The supplier may need time to confirm a subcontractor or may have legitimate confidentiality restrictions. Ask what information can be provided under a suitable agreement and decide whether the remaining evidence is adequate for the risk and the decision.
Review certificates, audits, and inspection claims
A certificate or audit report should be read as a document with a scope, not as a general promise. Identify the issuing organization, the legal entity and site, the activities or products covered, the issue and expiry dates, and any conditions. Ask whether the status can be checked with the issuer and whether the document applies to the site that will make your product.
Ask what was assessed and when. A management-system certificate, an audit report, a customer assessment, and a government inspection are different kinds of evidence. A document may cover a particular site or activity without addressing your formula, package, claims, or destination market. If the supplier provides an audit summary, ask how significant findings and corrective actions are handled and what level of detail can be reviewed under confidentiality.
ISO describes ISO 22716 as guidelines covering cosmetic production, control, storage, and shipment. [4] The public description of a standard does not show that a particular supplier follows it, holds a valid certificate, or meets every product requirement. Verify any claimed certification with the relevant issuing body and assess its site and scope. This guide draws on the ISO public description, not the full paid standard.
Similarly, ISO 19011:2026 provides guidance for auditing management systems; ISO states that applying ISO 19011 itself does not lead to certification. [5] If an audit is important to your decision, agree on the scope, criteria, auditor competence, access, reporting, and follow-up. The existence of an audit alone does not prove that every concern was examined or resolved.
FDA's cosmetics GMP inspection checklist can help buyers formulate questions about personnel, equipment, materials, production, laboratory controls, records, and complaints. [3] It is inspection guidance, not evidence that a named supplier complies with a particular rule. MoCRA directs FDA to establish cosmetic GMP requirements; check current requirements for the actual product and facility rather than treating a checklist as a universal binding test plan. [2]
A strong review connects the document to the decision: Does this evidence cover the actual entity, site, activity, period, and question we need to assess? If not, request a clarification or additional evidence. A valid facility certificate is not product approval, proof that a specific batch met its specification, or proof of a marketing claim.
Distinguish regulatory responsibilities from sales claims
Manufacturing and selling a cosmetic can involve several parties with different legal roles. A contract should assign tasks and information flows, but it does not by itself remove duties imposed by law. Identify the actual product, entities, facilities, markets, and intended claims before deciding which obligations apply.
United States
FDA describes requirements and authorities under the Modernization of Cosmetics Regulation Act of 2022, including matters concerning facility registration, product listing, safety substantiation, and serious adverse-event reporting. [2] Applicability and certain exemptions depend on the facts. Ask qualified advisers to determine the roles and obligations for the particular project rather than assuming that all suppliers or brands have the same status.
Be precise about registration and approval. FDA states that it does not issue certificates showing compliance with cosmetic facility registration or product listing requirements, and that registration or listing numbers do not mean FDA has approved the facility or products. [1] If a supplier presents a document as an “FDA registration certificate” or claims that a listing number proves approval, request clarification and verify the claim against FDA's own information.
Ask who will provide the information needed for the brand's market review, who will maintain relevant records, and who will receive and escalate complaints. If the supplier offers regulatory support, request a description of the work, its exclusions, the person responsible for final decisions, and the documents delivered. “Compliant for the US” is not an adequate substitute for identifying the product and requirements reviewed.
European Union and other destinations
The European Commission describes the EU framework for finished cosmetic products, including an EU responsible person, a product safety report, and centralized notification. [6] Identify who will serve in each applicable role and how the manufacturer will provide the information needed for the actual formula and package. Notification should not be presented as a general product approval.
Ask the supplier what information it can share with the appointed safety assessor, under what confidentiality conditions, and when. A brand may need access through an agreed professional channel if the formula is confidential. The arrangement should be practical enough for the people with legal responsibilities to complete their work.
Other destinations have their own rules, and the United Kingdom is a separate jurisdiction from the EU. If a supplier says it can support several markets, ask what that means for your product: formula review, labeling information, documentation, testing coordination, or another defined service. Confirm the current requirements with qualified professionals for each destination.
Evaluate samples and technical evidence
A sample helps you assess whether a product direction meets the brief. Record the sample identifier, formula version if available, package, date, and purpose. Compare candidates against the same relevant criteria, such as appearance, texture, fragrance, dispensing, and use experience. Consolidate feedback and identify the person authorized to accept or request changes.
Keep sensory feedback separate from safety, stability, performance, and regulatory evidence. A sample that feels pleasant does not establish that the finished product is safe under expected use or that an advertising claim is supported. Ask what information applies to the exact formula and package, what remains to be evaluated, and who will interpret it.
FDA explains that there is no single list of tests required for every US cosmetic product or ingredient; safety decisions can use relevant existing information and additional testing where needed. [7] That statement does not mean a brand can omit a needed evaluation or treat a supplier's generic report as sufficient for every product. Discuss the plan with qualified specialists and identify the report owner and access arrangements.
For a proposed marketing claim, ask what the supplier's evidence actually supports. Does it concern an ingredient or the finished product? Which version, conditions, and population were considered? Does the evidence match the statement the brand intends to make? The FTC's US advertising substantiation policy describes the need for a reasonable basis for objective claims. [11] A supplier's marketing phrase is not proof that your final claim is substantiated.
If a formula or package changes after sample review, record the new version and ask the appropriate people to assess the impact on existing evidence. Do not assume that every change requires the same response, or that a previous result automatically applies. A useful supplier can explain how it identifies a change and who participates in the decision.
Review quality and supply-chain evidence
The aim of supplier due diligence is to understand how the proposed partner will control and document your order. Ask for an overview of the product-specific specifications, incoming material and packaging identification, production and filling records, relevant checks, batch review, and change-control process. The exact documents and level of access should be appropriate to the product, risk, and agreement.
Discuss how the supplier will connect the finished batch to the materials and packaging used. Ask who can investigate an unexpected result, how the brand will be notified, and whether the contract gives the brand a review or approval role. If a subcontractor performs a material activity, identify how its work and records will be coordinated.
Ask for examples or descriptions of the process for handling a deviation, complaint, proposed substitution, or supply interruption. Do not ask a supplier to disclose another customer's confidential product information. A suitably anonymized example, procedure summary, controlled audit, or other agreed arrangement may help the buyer evaluate the process while respecting legitimate confidentiality.
Review the handoff after shipment as well. Who holds batch and distribution information? Who can place stock on hold? Who communicates with distributors and relevant authorities if an issue requires it? In the US, FDA's mandatory cosmetic recall authority is subject to specified conditions; a complaint is not automatically a recall. [2, 12] Identify the relevant legal and operational responsibilities for each market.
The question is not whether a supplier can provide a large stack of documents. It is whether the right people can obtain and assess the information needed to make product, batch, and post-market decisions. Record any access limitations and decide whether an alternative review arrangement addresses them.
Compare full cost, minimums, and schedules
Build a worksheet that lists all work and assumptions in each proposal. The unit price of filled product may exclude development, samples, product evaluation, packaging, decoration, freight, duties, taxes, storage, or other items. Ask suppliers to identify included and excluded costs and the currency and validity of each quote. If a fee is not yet known, mark it unknown rather than assuming zero.
Consider the following categories where relevant:
- Development and sample preparation, including agreed revisions.
- Formula or bulk product, filling, and finished-product packaging.
- Containers, closures, dispensers, labels, cartons, decoration, and tooling.
- Technical evaluations, laboratory work, reports, and regulatory support.
- Transport, insurance, import charges, taxes, warehousing, and delivery handling.
- Payment terms, changes, cancellation, rework, unused materials, and disposal.
The categories may be bundled differently by different suppliers. Ask each to explain the basis of its quotation so your worksheet compares equivalent scope. A lower unit price may still be preferable, but only after the remaining work and responsibility are visible.
Minimum order quantity, or MOQ, can apply at several levels: a finished product, a formula batch, a container, a printed label, or a custom component. Ask whether variants can share components and how unused materials are handled. The answer depends on the supplier and project. There is no universal MOQ for a cosmetic manufacturer, and a minimum for one component does not necessarily describe the whole order.
Review the schedule in the same way. Which date depends on the approved formula? Which component has not yet been sourced? When must artwork, testing, or market documentation be ready for the next decision? Ask what happens if the brand changes a claim or the supplier proposes a material substitution. A useful schedule identifies dependencies and decision owners rather than offering an unconditional promise.
For delivery, the contract may refer to an Incoterms rule and a named place. The International Chamber of Commerce explains that the rules address specified delivery, cost, and risk responsibilities but do not replace the full sales contract or settle matters such as title and payment. [10] Confirm the exact rule, version, named place, insurance, customs, and other terms with the appropriate commercial and legal advisers.
Review contracts, confidentiality, and continuity
Before committing to development or a production order, make sure the agreement describes the work and the decisions that matter. Depending on the project, that can include specifications, sample approval, acceptance criteria, changes, subcontracting, quality records, complaints, delivery, payment, and remedies. Have qualified counsel review the terms for the relevant jurisdictions.
Discuss the difference between a supplier's existing know-how and new work created for your project. Identify who owns or may use the formula, artwork, tooling, specifications, and reports, and under what conditions. Paying a development fee or buying finished goods does not by itself answer every ownership or transfer question. The agreement should state the rights and limits the parties actually intend.
Confidentiality requires more than placing a label on a document. WIPO describes trade-secret protection as dependent on the circumstances and the steps taken to keep relevant information secret, including controlled access and confidentiality arrangements. [8, 9] An NDA can be useful, but it is not a guarantee against every disclosure or independent development. Define protected information, permitted use and recipients, duration, return or destruction, and the process for sharing with necessary third parties. Obtain legal advice rather than assuming one template fits every market.
Ask how the business will continue if a material is unavailable, a supplier changes, or the relationship ends. Which materials and finished units belong to each party? Who may use the packaging tooling? What production and quality information can the brand or its appointed professional access? If transfer to another manufacturer is important, what technical information and rights would make that possible?
The practical handover matters as much as the wording of a right. A contract may permit an action, but the parties also need to know what records, specifications, samples, and contacts are required to carry it out. Agree on the process before the relationship is under pressure, and update it if the project changes.
Use a scorecard after the essential gates
A scorecard can make a comparison more transparent, but it should not turn missing evidence into a passing result. First define the mandatory, project-specific conditions and classify each as pass, hold, or not applicable with a reason. A hold means the responsible reviewer needs more information or a decision before the supplier can proceed. A high score for cost or communication cannot compensate for an unmet legal or essential technical requirement.
After the gates are resolved, the team can compare the remaining relevant factors. The following weights are an illustrative example only, not industry benchmarks or a substitute for expert judgment:
| Illustrative category | Example weight | What the team might review |
|---|---|---|
| Product and technical fit | 25 | Relevance of the proposal, sample plan, format, and defined scope |
| Quality system evidence | 25 | Actual site, documents, controls, audit scope, and open findings |
| Regulatory role and document readiness | 20 | Assigned responsibilities and access to information for the target market |
| Commercial scope | 15 | Comparable costs, minimums, assumptions, and schedule dependencies |
| Continuity and communication | 15 | Change process, contacts, information flow, and continuity plan |
The weights total 100 so the team can see how much emphasis it has assigned to each category. Adjust or replace them to reflect the project. Record the evidence, reviewer, date, and rationale behind each assessment. If information is unavailable, mark it unknown and explain its effect; do not invent a neutral score and proceed as though the risk were resolved.
Review the result as a team. A score can reveal a difference that needs discussion, but it cannot decide whether a legal requirement is met or whether an individual report supports a safety conclusion. Keep the gate decisions and the scorecard together with the final rationale, including any accepted limitations and follow-up actions.
Recognize red flags and investigate proportionately
Some responses warrant more work before a buyer commits. Examples include a supplier that cannot identify the entity or site responsible for a major activity; a certificate whose issuer, site, or scope cannot be verified; or a claim that an FDA registration number proves product approval. [1] Ask for an explanation and the evidence needed to resolve the inconsistency.
Other warning signs include a quote that leaves major work undefined, pressure to approve a claim without supporting evidence, or a refusal to explain how changes and complaints are handled. An estimate that appears to guarantee every market approval or delivery outcome without reviewing the actual product also needs careful scrutiny. Ask which assumptions and exclusions support the statement.
Treat uncertainty fairly. A supplier may be unable to share a full formula with every buyer or may not yet know which laboratory will perform a later task. Those limits are not automatically misconduct. Discuss controlled access, an independent reviewer, or a documented plan for obtaining the information. If the remaining gap affects a non-negotiable decision, maintain the hold until it is resolved.
Check your own process for red flags too. A rushed brief, inconsistent quantities sent to suppliers, or a decision based on incomplete costs can produce a misleading comparison even when each supplier responds accurately. Keep a common RFQ and record material changes sent to all candidates.
A hypothetical supplier comparison
Imagine a fictional brand seeking a moisturizer for named markets. It sends two suppliers the same product brief. Supplier A proposes an existing formula direction and a standard package. Supplier B proposes a development project and a different package. Both responses are preliminary and neither is scored in this example.
The brand first asks each supplier to identify the manufacturing entity and site, the formula and package assumptions, the sample and evaluation work included, the information available for market review, and the complete cost basis. It also asks who owns the relevant formula rights and how changes or a later transfer would be handled.
Several items remain unknown: whether each proposed package fits the brief, what additional evaluation may be needed, and which component minimums apply. The team records those as open questions rather than selecting the cheaper-looking quotation. It asks the appropriate technical, quality, regulatory, and commercial reviewers to assess the answers.
Only after the necessary conditions are resolved does the brand compare the proposals against its priorities. The example does not imply a winner. The right choice depends on the actual evidence, final scope, and business decision, not on the supplier's label or an invented score.
Frequently asked questions
How many cosmetic manufacturers should I compare?
There is no universal number. Compare enough credible options to understand the available scope and trade-offs while allowing your team to review the evidence properly. Use the same brief for each and avoid treating a long list of unverified quotations as a substitute for due diligence.
Does an FDA registration number mean a manufacturer is approved?
No. FDA states that a cosmetic facility registration or product listing number does not mean that FDA approved the facility or product, and that FDA does not issue certificates showing compliance with those requirements. [1] Determine which obligations apply to the actual entities and verify any claims with the relevant authority.
Is a factory audit necessary for every order?
The appropriate review depends on the product, risks, applicable requirements, available evidence, and your agreement. An audit can be one useful tool, but its scope, timing, criteria, and follow-up matter. A certificate or past audit should be evaluated against the actual site and work; neither automatically answers every product-specific question.
What is a reasonable MOQ for a cosmetic product?
There is no single reasonable quantity for every product. Minimums can reflect formula production, filling, packaging components, decoration, and supplier arrangements. Request the minimum for each relevant item and ask how changes in the brief affect the proposal. Compare the complete commitment, including any unused materials.
Should I share my formula before signing an NDA?
Consider what information is necessary at each stage and obtain legal advice on an appropriate confidentiality arrangement. Use an agreed secure channel and limit access to the people who need the information. An NDA is one possible safeguard, but WIPO notes that trade-secret protection depends on the circumstances and measures taken to maintain secrecy. [8, 9]
Can the manufacturer take full responsibility for market compliance?
A supplier can agree to perform defined tasks, but legal responsibilities depend on the product, jurisdiction, and roles of the actual parties. A contract should make the work and information flows clear; it cannot simply erase duties imposed by law. Obtain qualified advice and identify who is responsible for each decision and record. [2, 6]
What if a supplier cannot provide a report directly to my brand?
Ask why and what alternative access is possible. A confidential disclosure to an appointed safety assessor, a controlled audit, or an agreed summary may be appropriate in some circumstances. The people responsible for the decision still need sufficient information. If a necessary evidence gap remains, document it and hold the relevant decision until it is resolved.
Make the decision with evidence you can trace
Start with the actual product and destination, issue a consistent brief, and identify the conditions that must be met. Verify the entity and site, compare documented scope and complete costs, and ask qualified reviewers to resolve technical, quality, regulatory, and legal questions. Use a scorecard to make trade-offs visible only after the essential gates have been addressed.
Bring your product format, intended use and markets, formula starting point, package direction, estimated quantity, and document needs to a manufacturing discussion. A clear brief gives both the buyer and the potential partner a better basis for deciding what work is possible and what remains to be confirmed.
References
Sources checked 31 October 2026. Requirements, standards, and supplier status can change. ISO descriptions are based on the publicly available summaries, not the full paid standards. Obtain product- and jurisdiction-specific professional advice before making a legal or regulatory decision.
- US Food and Drug Administration. Registration & Listing of Cosmetic Product Facilities and Products, updated 9 September 2026.
- US Food and Drug Administration. Modernization of Cosmetics Regulation Act of 2022.
- US Food and Drug Administration. Good Manufacturing Practice (GMP) Guidelines/Inspection Checklist for Cosmetics.
- International Organization for Standardization. ISO 22716:2007, Cosmetics — Good Manufacturing Practices (GMP) — Guidelines on Good Manufacturing Practices, public abstract.
- International Organization for Standardization. ISO 19011:2026, Guidelines for auditing management systems, public description.
- European Commission. Cosmetics legislation.
- US Food and Drug Administration. Product Testing of Cosmetics.
- World Intellectual Property Organization. Trade Secrets.
- World Intellectual Property Organization. Guide to Trade Secrets and Innovation, Part IV: Trade secret management.
- International Chamber of Commerce. Incoterms 2020 Q&A.
- US Federal Trade Commission. Policy Statement Regarding Advertising Substantiation, 23 November 1984.
- US Food and Drug Administration. FDA Issues Final Guidance on Mandatory Cosmetic Recalls, 22 October 2026.
Developing a product of your own?
Share your brief with our team to explore formula, packaging and sampling options.
Discuss your project
